LUNG ADENOCARCINOMA, MIXED SUBTYPE

Clinical trials for LUNG ADENOCARCINOMA, MIXED SUBTYPE explained in plain language.

Never miss a new study

Get alerted when new LUNG ADENOCARCINOMA, MIXED SUBTYPE trials appear

Sign up with your email to follow new studies for LUNG ADENOCARCINOMA, MIXED SUBTYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug boosts standard treatment in fight against advanced lung cancer

Disease control Ongoing

This study is testing if adding an experimental drug called veliparib to standard chemotherapy and radiation works better for people with stage III non-small cell lung cancer that cannot be removed by surgery. The goal is to see if the combination helps patients live longer witho…

Matched conditions: LUNG ADENOCARCINOMA, MIXED SUBTYPE

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

LUNG ADENOCARCINOMA, MIXED SUBTYPE

Get alerted when new LUNG ADENOCARCINOMA, MIXED SUBTYPE trials appear

New drug boosts standard treatment in fight against advanced lung cancer